Chest
Volume 144, Issue 4, Supplement, October 2013, Page 88A
Allergy and AirwayImprovements in Lung Function With Tiotropium as Add-On Controller Therapy to ICS+LABA for Patients With Symptomatic Severe Asthma
Section snippets
Abstract
SESSION TITLE: Tiotropium and Asthma
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Monday, October 28, 2013 at 01:45 PM - 03:15 PM
PURPOSE: A considerable proportion of asthma patients remain symptomatic despite treatment with ICS+LABA, and there is a need for additional controller medications. We present results from one Phase II (trial 1: NCT00365560) and two replicate Phase III (trials 2a/2b: NCT00772538, NCT00776984) trials that assessed efficacy and safety of the long-acting
References (0)
Cited by (0)
Copyright © 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.